Riccardo Dalla-Favera, M.D.

Mr. Dalla-Favera is the Director of the Institute for Cancer Genetics at Columbia University and the Percy and Joanne Uris Professor of Pathology and Genetics and Development (Columbia University Medical School), in addition to serving as the Director of the Institute for Cancer Research at Columbia University. He currently is a member of the Scientific Advisory Boards of the Yale Cancer Center of the Albert Einstein College of Medicine Cancer Center and of the Lymphoma Research Foundation.

Kenneth Offit, M.D., M.P.H.

Mr. Offit is Chief of the Clinical Genetics service at Mt. Sinai Sloan-Kettering Cancer Center, with clinical expertise in genetic predisposition to cancer, lymphomas, and Hodkin’s disease as well as cancer risk counseling.  He has served as a member of the National Cancer Institute’s Cancer Genetics Working Group, and is currently chair of the subcommittee on cancer genetics at the American Society of Clinical Oncology.  In addition, Dr. Offit was listed in the New York Times Magazine as one of the top New York metropolitan cancer physicians in its 2008 edition.

Andrew D. Zelenetz, M.D., Ph.D.

Mr. Zelenetz is chief of lymphoma service and head of the Molecular Hemo-oncology Laboratory in the Dept. of Medicine at MSKCC.  He has published nearly one hundred papers in lymphoma research, and is board certified in internal medicine and medical oncology.  In addition to several national honors, Dr. Zelenetz serves on the committees of the Leukemia and Lymphoma Society of America, Lymphoma Research Foundation, and the National Cancer Institute, and was also listed by New York Magazine as one of the top cancer clinicians in the metropolitan New York area in 2008.

Victor Reuter, M.D.

Mr. Reuter is internationally renowned in the pathology of genito-urinary cancers.  He received his M.D. from University National Pedro Urena, Santo Domingo, Dominican Republic, and further training in pathology at the Thomas Jefferson University Hospital in Philadelphia and the MSKCC.  He is a Diplomate of the American Board of Pathology, and is currently Vice-Chairman Department of Pathology, MSKCC, and Professor of Pathology, Weill Medical College of Cornell University.  Dr. Reuter has published more than 250 papers and serves on the editorial boards of several prestigious Pathology journals.

Vundavalli V. Murty, Ph.D.

Mr. Murty is currently Director of the Cancer Cytogenetic Laboratory and Molecular Pathology at Columbia University. He is an Associate Editor of the journal Molecular Cancer and a Diplomate of the American Board of medical Genetics in the subspecialty, Clinical Cytogenetics. Dr. Murty has authored over 100 original research papers, book chapters, and reviews covering human and murine cancers.  Dr. Murty’s laboratory investigates the genetic mechanisms involved in testicular germ cell tumor and cervical cancer.